Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications

I. Truter, S. Shankar, M. Bennie, Mv Woerkom, B. Godman

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

There have been multiple reforms in South Africa to conserve resources including policies to enhance generic use, such as compulsory generic substitution and copayments. However, there are concerns with the limited knowledge of their impact. The objective of this paper was to determine utilization and expenditure of different proton pump inhibitors (PPIs). A retrospective drug utilization study was conducted on a prescription database of a medical aid administrator in 2010. The limited prescribing of single-sourced PPIs accounted for 21.5% of total prescriptions. The limited use of originators omeprazole and lansoprazole accounted for 1.8 and 1.4% of total prescriptions for the molecule, respectively. Generic prices accounted for 36-68% of the originator in 2010. Patients received on average 2.91 PPI prescriptions during the year.
Policies to enhance prescribing of generics appear working. Opportunities exist to further lower generic prices given low prices in some European countries.
LanguageEnglish
Pages123-131
Number of pages9
JournalJournal of Comparative Effectiveness Research
Volume4
Issue number2
DOIs
Publication statusPublished - Mar 2015

Fingerprint

Proton Pump Inhibitors
South Africa
Prescriptions
Drug Substitution
Lansoprazole
Drug Utilization
Omeprazole
Health Expenditures
Administrative Personnel
Databases

Keywords

  • Europe
  • proton pump inhibitor
  • South Africa
  • drug utilization
  • generics
  • drug prices

Cite this

@article{5e23ebf496864e2fa936413ccc246002,
title = "Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications",
abstract = "There have been multiple reforms in South Africa to conserve resources including policies to enhance generic use, such as compulsory generic substitution and copayments. However, there are concerns with the limited knowledge of their impact. The objective of this paper was to determine utilization and expenditure of different proton pump inhibitors (PPIs). A retrospective drug utilization study was conducted on a prescription database of a medical aid administrator in 2010. The limited prescribing of single-sourced PPIs accounted for 21.5{\%} of total prescriptions. The limited use of originators omeprazole and lansoprazole accounted for 1.8 and 1.4{\%} of total prescriptions for the molecule, respectively. Generic prices accounted for 36-68{\%} of the originator in 2010. Patients received on average 2.91 PPI prescriptions during the year. Policies to enhance prescribing of generics appear working. Opportunities exist to further lower generic prices given low prices in some European countries.",
keywords = "Europe, proton pump inhibitor, South Africa, drug utilization, generics, drug prices",
author = "I. Truter and S. Shankar and M. Bennie and Mv Woerkom and B. Godman",
year = "2015",
month = "3",
doi = "10.2217/cer.14.70",
language = "English",
volume = "4",
pages = "123--131",
journal = "Journal of Comparative Effectiveness Research",
issn = "2042-6313",
number = "2",

}

Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors : findings and implications. / Truter, I.; Shankar, S.; Bennie, M.; Woerkom, Mv; Godman, B.

In: Journal of Comparative Effectiveness Research, Vol. 4, No. 2, 03.2015, p. 123-131.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors

T2 - Journal of Comparative Effectiveness Research

AU - Truter, I.

AU - Shankar, S.

AU - Bennie, M.

AU - Woerkom, Mv

AU - Godman, B.

PY - 2015/3

Y1 - 2015/3

N2 - There have been multiple reforms in South Africa to conserve resources including policies to enhance generic use, such as compulsory generic substitution and copayments. However, there are concerns with the limited knowledge of their impact. The objective of this paper was to determine utilization and expenditure of different proton pump inhibitors (PPIs). A retrospective drug utilization study was conducted on a prescription database of a medical aid administrator in 2010. The limited prescribing of single-sourced PPIs accounted for 21.5% of total prescriptions. The limited use of originators omeprazole and lansoprazole accounted for 1.8 and 1.4% of total prescriptions for the molecule, respectively. Generic prices accounted for 36-68% of the originator in 2010. Patients received on average 2.91 PPI prescriptions during the year. Policies to enhance prescribing of generics appear working. Opportunities exist to further lower generic prices given low prices in some European countries.

AB - There have been multiple reforms in South Africa to conserve resources including policies to enhance generic use, such as compulsory generic substitution and copayments. However, there are concerns with the limited knowledge of their impact. The objective of this paper was to determine utilization and expenditure of different proton pump inhibitors (PPIs). A retrospective drug utilization study was conducted on a prescription database of a medical aid administrator in 2010. The limited prescribing of single-sourced PPIs accounted for 21.5% of total prescriptions. The limited use of originators omeprazole and lansoprazole accounted for 1.8 and 1.4% of total prescriptions for the molecule, respectively. Generic prices accounted for 36-68% of the originator in 2010. Patients received on average 2.91 PPI prescriptions during the year. Policies to enhance prescribing of generics appear working. Opportunities exist to further lower generic prices given low prices in some European countries.

KW - Europe

KW - proton pump inhibitor

KW - South Africa

KW - drug utilization

KW - generics

KW - drug prices

U2 - 10.2217/cer.14.70

DO - 10.2217/cer.14.70

M3 - Article

VL - 4

SP - 123

EP - 131

JO - Journal of Comparative Effectiveness Research

JF - Journal of Comparative Effectiveness Research

SN - 2042-6313

IS - 2

ER -